Literature DB >> 17027265

Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines.

Sandeep A Kotharkar1, Devanand B Shinde.   

Abstract

A new series of 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines was synthesized and submitted to antibacterial and antifungal activities. Result of the antimicrobial screening showed the compound 4j being the most effective among the various treatments in antimicrobial screening. Compounds 4c, 4d, 4k, and 4l showed moderate activity against the microorganisms tested.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17027265     DOI： 10.1016/j.bmcl.2006.09.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  The molecular diversity scope of 4-hydroxycoumarin in the synthesis of heterocyclic compounds via multicomponent reactions.

Authors:  Ghodsi Mohammadi Ziarani; Razieh Moradi; Tahereh Ahmadi; Parisa Gholamzadeh
Journal:  Mol Divers       Date:  2019-01-29       Impact factor: 2.943

2.  Organocatalytic three-component cascade reaction for the synthesis of spiro[indeno[1,2-b]furan]-triones.

Authors:  Somayeh Ahadi; Maryam Abaszadeh; Ayoob Bazgir
Journal:  Mol Divers       Date:  2012-03-15       Impact factor: 2.943

3.  1-Ethyl-3-methyl-quinoxalin-2(1H)-one.

Authors:  Hanane Benzeid; Laure Vendier; Youssef Ramli; Bernard Garrigues; El Mokhtar Essassi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-31

4.  Eco-friendly approach to access of quinoxaline derivatives using nanostructured pyrophosphate Na2PdP2O7 as a new, efficient and reusable heterogeneous catalyst.

Authors:  Karim Dânoun; Younes Essamlali; Othmane Amadine; Hassan Mahi; Mohamed Zahouily
Journal:  BMC Chem       Date:  2020-02-03

5.  Synthesis of Chromeno[3,4-b]piperazines by an Enol-Ugi/Reduction/Cyclization Sequence.

Authors:  Ana Bornadiego; Ana G Neo; Carlos F Marcos
Journal:  Molecules       Date:  2021-02-27       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.